ClinicalTrials.Veeva

Menu

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation (AHF-CODE-R)

C

Central Hospital, Nancy, France

Status

Enrolling

Conditions

Acute Heart Failure

Treatments

Procedure: Telephone interview
Behavioral: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Procedure: Biological: Blood sample retrieved for biological assessment and biobanking
Procedure: Clinical examination centered on congestion
Procedure: Cardio-pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography

Study type

Interventional

Funder types

Other

Identifiers

NCT04343443
2019PI188-3

Details and patient eligibility

About

The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure.

The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalised for acute heart failure.
  • Patients with reduced ejection fraction (Ejection Fraction <40%) or (40% ≤ Ejection Fraction < 50)
  • Patients considered clinically discharging from hospitalisation for acute heart failure.
  • Age ≥18 years
  • Patients having received complete information regarding the study design and having signed their informed consent form.
  • Patient affiliated to or beneficiary of a social security scheme.

Exclusion criteria

  • Comorbidity for which the life expectancy is ≤ 3 months
  • Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate <15 ml/min/m2 at inclusion.
  • History of lobectomy or pneumonectomy lung surgery
  • Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.
  • Pregnant woman, parturient or nursing mother
  • Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice) Adult person who is unable to give consent
  • Person deprived of liberty by a judicial or administrative decision,
  • Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Patients hospitalized for acute heart failure
Other group
Description:
Patients hospitalized for acute heart failure will undergo the following evaluations: * Clinical examination centered on congestion * Cardiopulmonary , peritoneal , jugular and renal venous Doppler ultrasounds * Blood sample retrieved for biological assessment and biobanking * Telephone interview
Treatment:
Behavioral: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Procedure: Clinical examination centered on congestion
Procedure: Cardio-pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography
Procedure: Biological: Blood sample retrieved for biological assessment and biobanking
Procedure: Telephone interview

Trial contacts and locations

1

Loading...

Central trial contact

Nicolas GIRERD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems